Literature DB >> 19036118

Targeting Wnt pathway in lymphoma and myeloma cells.

Matthias Schmidt1, Elisabeth Sievers, Tomoyuki Endo, Desheng Lu, Dennis Carson, Ingo G H Schmidt-Wolf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19036118     DOI： 10.1111/j.1365-2141.2008.07503.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  13 in total

1.  Large-scale analysis of DNA methylation in chronic lymphocytic leukemia.

Authors:  Farahnaz B Rahmatpanah; Stephanie Carstens; Sam I Hooshmand; Elise C Welsh; Ozy Sjahputera; Kristen H Taylor; Lynda B Bennett; Huidong Shi; J Wade Davis; Gerald L Arthur; Tait D Shanafelt; Neil E Kay; James E Wooldridge; Charles W Caldwell
Journal:  Epigenomics       Date:  2009-10       Impact factor: 4.778

2.  Ethacrynic acid and cinnamic acid combination exhibits selective anticancer effects on K562 chronic myeloid leukemia cells.

Authors:  Münevver Yenigül; İsmail Akçok; Emel Başak Gencer Akçok
Journal:  Mol Biol Rep       Date:  2022-05-18       Impact factor: 2.742

Review 3.  Role of Wnt canonical pathway in hematological malignancies.

Authors:  Xueling Ge; Xin Wang
Journal:  J Hematol Oncol       Date:  2010-09-15       Impact factor: 17.388

4.  Wnt signaling inhibits CTL memory programming.

Authors:  Zhengguo Xiao; Zhifeng Sun; Kendra Smyth; Lei Li
Journal:  Mol Immunol       Date:  2013-08-01       Impact factor: 4.407

Review 5.  Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy.

Authors:  Yung Lyou; Amber N Habowski; George T Chen; Marian L Waterman
Journal:  Br J Pharmacol       Date:  2017-08-24       Impact factor: 8.739

6.  Transcriptional silencing of the Wnt-antagonist DKK1 by promoter methylation is associated with enhanced Wnt signaling in advanced multiple myeloma.

Authors:  Kinga A Kocemba; Richard W J Groen; Harmen van Andel; Marie José Kersten; Karène Mahtouk; Marcel Spaargaren; Steven T Pals
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

7.  Metadherin contributes to the pathogenesis of diffuse large B-cell lymphoma.

Authors:  Xueling Ge; Xiao Lv; Lili Feng; Xiaoqian Liu; Junming Gao; Na Chen; Xin Wang
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

8.  Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells.

Authors:  Maria Zeniou; Marie Fève; Samir Mameri; Jihu Dong; Christophe Salomé; Wanyin Chen; Elias A El-Habr; Fanny Bousson; Mohamadou Sy; Julie Obszynski; Alexandre Boh; Pascal Villa; Suzana Assad Kahn; Bruno Didier; Dominique Bagnard; Marie-Pierre Junier; Hervé Chneiweiss; Jacques Haiech; Marcel Hibert; Marie-Claude Kilhoffer
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

9.  Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway.

Authors:  Desheng Lu; Jerry X Liu; Tomoyuki Endo; Haowen Zhou; Shiyin Yao; Karl Willert; Ingo G H Schmidt-Wolf; Thomas J Kipps; Dennis A Carson
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

10.  Wnt/ß-catenin: a new therapeutic approach to acute myeloid leukemia.

Authors:  Y Kim; S Thanendrarajan; I G H Schmidt-Wolf
Journal:  Leuk Res Treatment       Date:  2011-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.